SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054747
Filing Date
2021-11-05
Accepted
2021-11-05 08:02:56
Documents
52
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-10q_20210930.htm   iXBRL 10-Q 1704092
2 EX-31.1 crnx-ex311_7.htm EX-31.1 21625
3 EX-31.2 crnx-ex312_6.htm EX-31.2 21578
4 EX-32.1 crnx-ex321_8.htm EX-32.1 6936
  Complete submission text file 0001564590-21-054747.txt   6009285

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crnx-20210930.xsd EX-101.SCH 36305
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crnx-20210930_cal.xml EX-101.CAL 33954
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crnx-20210930_def.xml EX-101.DEF 108208
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20210930_lab.xml EX-101.LAB 332471
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20210930_pre.xml EX-101.PRE 234982
10 EXTRACTED XBRL INSTANCE DOCUMENT crnx-10q_20210930_htm.xml XML 1092357
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 211382386
SIC: 2834 Pharmaceutical Preparations